A Rare Presentation of an Adverse Reaction to Minocycline

Francisca Manoel1, José Maria Lupi1, Isabel V Coelho1

  • 1Pediatrics, Hospital do Espírito Santo de Évora, Évora, PRT.

Cureus
|October 14, 2024
PubMed

Insights

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe reaction often missed. Prompt diagnosis and adjusted corticosteroid therapy are crucial for managing DRESS symptoms and preventing recurrence.

Area of Science:

  • Clinical immunology
  • Dermatology
  • Pharmacology

Background:

  • Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare but severe adverse drug reaction.
  • Typically associated with antibiotics and anticonvulsants, DRESS presents with diverse systemic manifestations.

Observation:

  • A 17-year-old female presented with symptoms mimicking serum-like sickness after initiating minocycline.
  • Initial treatment and minocycline suspension led to symptom recurrence, including renal and respiratory compromise, upon corticosteroid taper.

Findings:

  • Chest CT revealed interstitial pneumonitis, prompting a revised diagnosis of DRESS.
  • Adjusted corticosteroid therapy led to significant symptom improvement, underscoring the importance of appropriate management.

Implications:

  • This case emphasizes the diagnostic challenges in DRESS, particularly when initial presentations are atypical.
  • Highlights the critical need for a comprehensive patient evaluation and a tailored, adaptive treatment strategy for DRESS.
  • Underscores the importance of considering DRESS in patients with severe drug reactions, even with initial misdiagnoses.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
783
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K
Allergic Reactions02:06

Allergic Reactions

Overview
27.3K
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
394
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
249
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
817